Patent intelligence · US
US 11419835
Method of treatment and prevention of bacterial vaginosis
Method of treatment and prevention of bacterial vaginosis
Patent details — US 11419835
- Jurisdiction
- US
- Status
- granted
- Grant date
- Aug 23, 2022
- Expiration
- Aug 18, 2042
- Applicant
- Evofem, Inc.
- Claims
- 21
- CPC classes
- A61K, A61K31/19, A61K47/12, A61K47/36
Quick answer
US 11419835 (Method of treatment and prevention of bacterial vaginosis) is held by Evofem, Inc.. Status: granted. Granted Aug 23, 2022. Expires Aug 18, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Evofem, Inc.
- Grant date
- Expiration
- Claims
- 21
- CPC classes
- A61K, A61K31/19, A61K47/12, A61K47/36, A61K47/38, A61K9/0034
More from Evofem, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12280037
Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof
granted -
US 12172969
Deuterated secnidazole for use in the treatment of bacterial vaginosis and methods and uses thereof
granted -
US 11992472
Compositions and methods for enhancing the efficacy of contraceptive microbicides
granted -
US 11439610
Compositions and methods for enhancing the efficacy of contraceptive microbicides
granted -
US 11337989
Compositions and methods for inhibiting inflammation and diseases using an alginic acid-based antimicrobial compound
granted -
US 10568855
Compositions and methods for enhancing the efficacy of contraceptive microbicides
granted -
US 9566232
Compositions and methods for enhancing the efficacy of contraceptive microbicides
granted
Frequently asked questions
What is US patent 11419835?
US 11419835 (Method of treatment and prevention of bacterial vaginosis) is held by Evofem, Inc.. Status: granted. Granted Aug 23, 2022. Expires Aug 18, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11419835?
Evofem, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 8 pharmaceutical patents for this assignee.
When does US 11419835 expire?
Our index shows an expiration date of Aug 18, 2042 (16 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.